Molecular Diagnostics

MUDr. Lužbeták started his medical journey at Jessenius Faculty of Medicine in Martin (Comenius University in Bratislava) studying general medicine. He continued at Dresden International University, where he studied preventive medicine and graduated with a M.Sc. degree in 2016. MUDr. Lužbeták is engaged in scientific activities and presents results at international scientific forums. He works with leading experts and clinics from around the world. MUDr. Lužbeták is most pleased with the patient’s smile after successful treatment and when they can return to living life to the fullest. 

MUDr. Lužbeták ‘s is part of the NextGen Oncology Group whose purpose is to develop patient-focused, personalized diagnostics & advanced therapies for patients and the doctors who treat them and to find new hope through science-based approaches.

Every patient is unique, every tumor is unique and deploys its own set of complex molecular interactions. There is still an unmet need for personalized diagnostics to inform clinicians on the best treatment options. Companion diagnostics have the extraordinary power to connect a patient’s unique genetic profile to targeted, personalized treatment options. NextGen delivers cancer diagnostics insights that provide doctors with precision treatment strategies that can provide better care to patients.